Advertisement

Implementation of a Clinical Pharmacogenomics Service in a Large Freestanding Pediatric Health System

Published:September 28, 2022DOI:https://doi.org/10.1016/j.yamp.2022.05.004

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Molecular Pathology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Luczak T.
        • Brown S.J.
        • Armbruster D.
        • et al.
        Strategies and settings of clinical pharmacogenetic implementation: a scoping review of pharmacogenetics programs.
        Pharmacogenomics. 2021; 22: 345-364
        • Gregornik D.
        • Salyakina D.
        • Brown M.
        • et al.
        Pediatric pharmacogenomics: challenges and opportunities: on behalf of the Sanford Children’s Genomic Medicine Consortium.
        Pharmacogenomics J. 2021; 21: 8-19
        • Brown J.T.
        • Ramsey L.B.
        • Van Driest S.L.
        • et al.
        Characterizing Pharmacogenetic Testing Among Children’s Hospitals.
        Clin Transl Sci. 2021; 14: 692-701
        • Ramsey L.B.
        • Brown J.T.
        • Vear S.I.
        • et al.
        Gene-Based Dose Optimization in Children.
        Annu Rev Pharmacol Toxicol. 2020; 60: 311-331
        • Brown J.T.
        • Bishop J.R.
        • Sangkuhl K.
        • et al.
        Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine Therapy.
        Clin Pharmacol Ther. 2019; 106: 94-102
        • Moriyama B.
        • Obeng A.O.
        • Barbarino J.
        • et al.
        Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy.
        Clin Pharmacol Ther. 2017; 102: 45-51
        • Funk R.S.
        • Brown J.T.
        • Abdel-Rahman S.M.
        Pediatric pharmacokinetics: human development and drug disposition.
        Pediatr Clin North Am. 2012; 59: 1001-1016
        • Green D.J.
        • Mummaneni P.
        • Kim I.W.
        • et al.
        Pharmacogenomic information in FDA-approved drug labels: Application to pediatric patients.
        Clin Pharmacol Ther. 2016; 99: 622-632
        • Roden D.M.
        • Van Driest S.L.
        • Mosley J.D.
        • et al.
        Benefit of Preemptive Pharmacogenetic Information on Clinical Outcome.
        Clin Pharmacol Ther. 2018; 103: 787-794
        • Blanchard C.
        • Livet M.
        • Ward C.
        • et al.
        The Active Implementation Frameworks: A roadmap for advancing implementation of Comprehensive Medication Management in Primary care.
        Res Social Adm Pharm. 2017; 13: 922-929
        • Vande Voort J.L.
        • Orth S.S.
        • Shekunov J.
        • et al.
        A Randomized Controlled Trial of Combinatorial Pharmacogenetics Testing in Adolescent Depression.
        J Am Acad Child Adolesc Psychiatry. 2022; 61: 46-55
        • Sepe D.M.
        • McWilliams T.
        • Chen J.
        • et al.
        Germline genetic variation and treatment response on CCG-1891.
        Pediatr Blood Cancer. 2012; 58: 695-700
        • Relling M.V.
        • Pui C.H.
        • Cheng C.
        • et al.
        Thiopurine methyltransferase in acute lymphoblastic leukemia.
        Blood. 2006; 107: 843-844
        • Moyer A.M.
        • Caraballo P.J.
        The challenges of implementing pharmacogenomic testing in the clinic.
        Expert Rev Pharmacoecon Outcomes Res. 2017; 17: 567-577
        • Roden D.M.
        • McLeod H.L.
        • Relling M.V.
        • et al.
        Pharmacogenomics.
        Lancet. 2019; 394: 521-532
        • Luzum J.A.
        • Pakyz R.E.
        • Elsey A.R.
        • et al.
        The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems.
        Clin Pharmacol Ther. 2017; 102: 502-510
        • Brown J.T.
        • Gregornik D.B.
        • Jorgenson A.
        • et al.
        Sertraline dosing trends in children and adolescents stratified by CYP2C19 genotype.
        Pharmacogenomics. 2022; 23: 247-253
        • Hippman C.
        • Nislow C.
        Pharmacogenomic Testing: Clinical Evidence and Implementation Challenges.
        J Pers Med. 2019; 9: E40
        • Scott S.A.
        • Scott E.R.
        • Seki Y.
        • et al.
        Development and Analytical Validation of a 29 Gene Clinical Pharmacogenetic Genotyping Panel: Multi-Ethnic Allele and Copy Number Variant Detection.
        Clin Transl Sci. 2021; 14: 204-213
        • Zhou Y.
        • Ingelman-Sundberg M.
        • Lauschke V.M.
        Worldwide Distribution of Cytochrome P450 Alleles: A Meta-analysis of Population-scale Sequencing Projects.
        Clin Pharmacol Ther. 2017; 102: 688-700
        • Pratt V.M.
        • Turner A.
        • Broeckel U.
        • et al.
        Characterization of Reference Materials with an Association for Molecular Pathology Pharmacogenetics Working Group Tier 2 Status: CYP2C9, CYP2C19, VKORC1, CYP2C Cluster Variant, and GGCX: A GeT-RM Collaborative Project.
        J Mol Diagn. 2021; 23: 952-958
        • Pratt V.M.
        • Cavallari L.H.
        • Del Tredici A.L.
        • et al.
        Recommendations for Clinical CYP2D6 Genotyping Allele Selection: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and the European Society for Pharmacogenomics and Personalized Therapy.
        J Mol Diagn. 2021; 23: 1047-1064
        • Mroz P.
        • Michel S.
        • Allen J.D.
        • et al.
        Development and Implementation of In-House Pharmacogenomic Testing Program at a Major Academic Health System.
        Front Genet. 2021; 12: 712602